Immune Related Adverse Events of the Thyroid – A Narrative Review

Immune checkpoints are small molecules present on the cell surface of T-lymphocytes. They maintain self-tolerance and regulate the amplitude and duration of T-cell responses. Antagonism of immune checkpoints with monoclonal antibodies (immune checkpoint inhibitors) is a rapidly evolving field of ant...

Full description

Bibliographic Details
Main Authors: Christopher A. Muir, Venessa H. M. Tsang, Alexander M. Menzies, Roderick J. Clifton-Bligh
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-05-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2022.886930/full
_version_ 1811256440028921856
author Christopher A. Muir
Venessa H. M. Tsang
Venessa H. M. Tsang
Venessa H. M. Tsang
Alexander M. Menzies
Alexander M. Menzies
Alexander M. Menzies
Alexander M. Menzies
Roderick J. Clifton-Bligh
Roderick J. Clifton-Bligh
Roderick J. Clifton-Bligh
author_facet Christopher A. Muir
Venessa H. M. Tsang
Venessa H. M. Tsang
Venessa H. M. Tsang
Alexander M. Menzies
Alexander M. Menzies
Alexander M. Menzies
Alexander M. Menzies
Roderick J. Clifton-Bligh
Roderick J. Clifton-Bligh
Roderick J. Clifton-Bligh
author_sort Christopher A. Muir
collection DOAJ
description Immune checkpoints are small molecules present on the cell surface of T-lymphocytes. They maintain self-tolerance and regulate the amplitude and duration of T-cell responses. Antagonism of immune checkpoints with monoclonal antibodies (immune checkpoint inhibitors) is a rapidly evolving field of anti-cancer immunotherapy and has become standard of care in management of many cancer subtypes. Immune checkpoint inhibition is an effective cancer treatment but can precipitate immune related adverse events (irAEs). Thyroid dysfunction is the most common endocrine irAE and can occur in up to 40% of treated patients. Both thyrotoxicosis and hypothyroidism occur. The clinical presentation and demographic associations of thyrotoxicosis compared to hypothyroidism suggest unique entities with different etiologies. Thyroid irAEs, particularly overt thyrotoxicosis, are associated with increased immune toxicity in other organ systems, but also with longer progression-free and overall survival. Polygenic risk scores using susceptibility loci associated with autoimmune thyroiditis predict development of checkpoint inhibitor associated irAEs, suggesting potentially shared mechanisms underpinning their development. Our review will provide an up-to-date summary of knowledge in the field of thyroid irAEs. Major focus will be directed toward pathogenesis (including genetic factors shared with autoimmune thyroid disease), demographic associations, clinical presentation and course, treatment, and the relationship with cancer outcomes.
first_indexed 2024-04-12T17:41:07Z
format Article
id doaj.art-1c6cb87d532a44eb838e1804ba9ff5d0
institution Directory Open Access Journal
issn 1664-2392
language English
last_indexed 2024-04-12T17:41:07Z
publishDate 2022-05-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Endocrinology
spelling doaj.art-1c6cb87d532a44eb838e1804ba9ff5d02022-12-22T03:22:48ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922022-05-011310.3389/fendo.2022.886930886930Immune Related Adverse Events of the Thyroid – A Narrative ReviewChristopher A. Muir0Venessa H. M. Tsang1Venessa H. M. Tsang2Venessa H. M. Tsang3Alexander M. Menzies4Alexander M. Menzies5Alexander M. Menzies6Alexander M. Menzies7Roderick J. Clifton-Bligh8Roderick J. Clifton-Bligh9Roderick J. Clifton-Bligh10Faculty of Medicine and Health, The University of Sydney, Sydney, NSW, AustraliaFaculty of Medicine and Health, The University of Sydney, Sydney, NSW, AustraliaCancer Genetics, Kolling Institute of Medical Research, Sydney, NSW, AustraliaDepartment of Endocrinology, Royal North Shore Hospital, Sydney, NSW, AustraliaFaculty of Medicine and Health, The University of Sydney, Sydney, NSW, AustraliaMelanoma Institute Australia, The University of Sydney, Sydney, NSW, AustraliaDepartment of Medical Oncology, Royal North Shore Hospital, Sydney, NSW, AustraliaDepartment of Medical Oncology, Mater Hospital, Sydney, NSW, AustraliaFaculty of Medicine and Health, The University of Sydney, Sydney, NSW, AustraliaCancer Genetics, Kolling Institute of Medical Research, Sydney, NSW, AustraliaDepartment of Endocrinology, Royal North Shore Hospital, Sydney, NSW, AustraliaImmune checkpoints are small molecules present on the cell surface of T-lymphocytes. They maintain self-tolerance and regulate the amplitude and duration of T-cell responses. Antagonism of immune checkpoints with monoclonal antibodies (immune checkpoint inhibitors) is a rapidly evolving field of anti-cancer immunotherapy and has become standard of care in management of many cancer subtypes. Immune checkpoint inhibition is an effective cancer treatment but can precipitate immune related adverse events (irAEs). Thyroid dysfunction is the most common endocrine irAE and can occur in up to 40% of treated patients. Both thyrotoxicosis and hypothyroidism occur. The clinical presentation and demographic associations of thyrotoxicosis compared to hypothyroidism suggest unique entities with different etiologies. Thyroid irAEs, particularly overt thyrotoxicosis, are associated with increased immune toxicity in other organ systems, but also with longer progression-free and overall survival. Polygenic risk scores using susceptibility loci associated with autoimmune thyroiditis predict development of checkpoint inhibitor associated irAEs, suggesting potentially shared mechanisms underpinning their development. Our review will provide an up-to-date summary of knowledge in the field of thyroid irAEs. Major focus will be directed toward pathogenesis (including genetic factors shared with autoimmune thyroid disease), demographic associations, clinical presentation and course, treatment, and the relationship with cancer outcomes.https://www.frontiersin.org/articles/10.3389/fendo.2022.886930/fullimmune related adverse eventscheckpoint inhibitorthyrotoxicosishypothyroidismthyroid
spellingShingle Christopher A. Muir
Venessa H. M. Tsang
Venessa H. M. Tsang
Venessa H. M. Tsang
Alexander M. Menzies
Alexander M. Menzies
Alexander M. Menzies
Alexander M. Menzies
Roderick J. Clifton-Bligh
Roderick J. Clifton-Bligh
Roderick J. Clifton-Bligh
Immune Related Adverse Events of the Thyroid – A Narrative Review
Frontiers in Endocrinology
immune related adverse events
checkpoint inhibitor
thyrotoxicosis
hypothyroidism
thyroid
title Immune Related Adverse Events of the Thyroid – A Narrative Review
title_full Immune Related Adverse Events of the Thyroid – A Narrative Review
title_fullStr Immune Related Adverse Events of the Thyroid – A Narrative Review
title_full_unstemmed Immune Related Adverse Events of the Thyroid – A Narrative Review
title_short Immune Related Adverse Events of the Thyroid – A Narrative Review
title_sort immune related adverse events of the thyroid a narrative review
topic immune related adverse events
checkpoint inhibitor
thyrotoxicosis
hypothyroidism
thyroid
url https://www.frontiersin.org/articles/10.3389/fendo.2022.886930/full
work_keys_str_mv AT christopheramuir immunerelatedadverseeventsofthethyroidanarrativereview
AT venessahmtsang immunerelatedadverseeventsofthethyroidanarrativereview
AT venessahmtsang immunerelatedadverseeventsofthethyroidanarrativereview
AT venessahmtsang immunerelatedadverseeventsofthethyroidanarrativereview
AT alexandermmenzies immunerelatedadverseeventsofthethyroidanarrativereview
AT alexandermmenzies immunerelatedadverseeventsofthethyroidanarrativereview
AT alexandermmenzies immunerelatedadverseeventsofthethyroidanarrativereview
AT alexandermmenzies immunerelatedadverseeventsofthethyroidanarrativereview
AT roderickjcliftonbligh immunerelatedadverseeventsofthethyroidanarrativereview
AT roderickjcliftonbligh immunerelatedadverseeventsofthethyroidanarrativereview
AT roderickjcliftonbligh immunerelatedadverseeventsofthethyroidanarrativereview